The EVP,Pres MedSurg of Boston Scientific Corp (BSX) is Selling Shares


Today, the EVP,Pres MedSurg of Boston Scientific Corp (BSX), David A. Pierce, sold shares of BSX for $175K.

Following David A. Pierce’s last BSX Sell transaction on February 26, 2014, the stock climbed by 22.0%.

See today’s analyst top recommended stocks >>

BSX’s market cap is $48.96B and the company has a P/E ratio of 75.28. Currently, Boston Scientific Corp has an average volume of 7.49M.

Based on 18 analyst ratings, the analyst consensus is Strong Buy with an average price target of $42.41, reflecting a 18.2% upside. One of the top 25 analysts, according to TipRanks.com, recently recommended Buy BSX with a $40 price target.

The insider sentiment on Boston Scientific Corp has been negative according to 150 insider trades in the past three months. This sentiment is lower than the average sentiment of company insiders in this sector.

David A. Pierce’s trades have generated a -6.5% average return based on past transactions. DailyInsider proprietary algorithm detects trades by the most influential insiders and selects attractive trading opportunities daily. To subscribe to the DailyInsider visit this page.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.

Boston Scientific Corp. engages in the development, manufacture and marketing of medical devices that are used in interventional medical specialties. It operates through the following segments: Cardiovascular, Rhythm Management, and MedSurg.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts